The central government has banned the production, sale and distribution of tablets containing more than 100 mg of the popular painkiller drug Nimesulide (Nimesulide 100mg Ban India). Health Ministry took this step Health But it has been raised in view of the potentially serious risks. This ban has come into effect from Monday, February 1, 2026.
According to the Health Ministry’s notification, India’s apex health research body ICMR (Indian Council of Medical Research) had warned on the risks of medicines containing more than 100 mg of nimesulide. The ministry said the high-dose nimesulide drug could be risky for human use.
For this reason, under the Drugs and Cosmetics Act, 1940 and after consultation with the Drug Technical Advisory Board, the government imposed this ban with immediate effect.
risk of liver damage
The Health Ministry has warned that Nimesulide is a non-steroidal anti-inflammatory drug (NSAID). It reduces pain and swelling, but there is a serious risk of liver damage if taken in high doses. Therefore the use of high dosage pills is not considered safe for human health.
Medicine will be recalled from the market
This ban will affect only tablets with dosages of 100 mg and above. Low quantity medicines will be available in the market. All pharmaceutical companies will now have to stop producing high dose nimesulide drugs. Apart from this, such medicines already in the market will be recalled.
Patients will be given alternative medicine
Due to this ban, painkillers of some big companies may be removed from the drug stores. Patients will now be given alternative painkillers on the advice of the doctor. Experts said that it will now be difficult to take the medicine without the guidance of a doctor, which will prevent wrong and dangerous use of the medicine.
The Central Government has banned the production, sale and distribution of Nimesulide drugs with dosage more than 100 mg. This step has been taken in view of the serious risks to human health. The Health Ministry has warned that high doses carry the risk of liver damage. Low-dose medications will continue to be available, while higher-dose medications will be recalled from the market. Alternative painkillers will be made available to the patients as per the doctor’s advice.
Comments are closed.